All content on this site is intended for healthcare professionals only. By acknowledging this message and accessing the information on this website you are confirming that you are a Healthcare Professional. If you are a patient or carer, please visit the Lymphoma Coalition.

The Lymphoma Hub uses cookies on this website. They help us give you the best online experience. By continuing to use our website without changing your cookie settings, you agree to our use of cookies in accordance with our updated Cookie Policy

Introducing

Now you can personalise
your Lymphoma Hub experience!

Bookmark content to read later

Select your specific areas of interest

View content recommended for you

Find out more
  TRANSLATE

The Lymphoma Hub website uses a third-party service provided by Google that dynamically translates web content. Translations are machine generated, so may not be an exact or complete translation, and the Lymphoma Hub cannot guarantee the accuracy of translated content. The Lymphoma Hub and its employees will not be liable for any direct, indirect, or consequential damages (even if foreseeable) resulting from use of the Google Translate feature. For further support with Google Translate, visit Google Translate Help.

Steering CommitteeAbout UsNewsletterContact
LOADING
You're logged in! Click here any time to manage your account or log out.
LOADING
You're logged in! Click here any time to manage your account or log out.

The Lymphoma & CLL Hub is an independent medical education platform, sponsored by Beigene, Johnson & Johnson and Roche, and supported through educational grants from Bristol Myers Squibb, Incyte, Ipsen Biopharmaceuticals, Lilly, and Pfizer. View funders.

Make a contribution to the Lymphoma Hub

How does my contribution help?

HCPs need the latest information to make the best choices for their patients. Your support matters! Scientific data is expanding rapidly, with 426,000 clinical studies registered in 2023 – a 163% increase from 2022. PubMed-indexed publications have doubled since 2014, exceeding 30 million articles by 2024. For example, in lymphoma alone, approximately 15,000 clinical papers were published in 2023, translating to almost 40 papers per day, or 2 per hour!

The Lymphoma Hub is a centralized resource for the latest news and insights on lymphoma, helping HCPs stay current in this rapidly evolving field. Your contributions enable us to continue providing round-the-clock updates, ensuring HCPs have access to everything they need to know about lymphoma in one place.

If you would like to know more before choosing to make a contribution, please read our FAQs.

FAQs

Why are you asking for contributions?

We are a for-profit and have created the hub through funding from the pharmaceutical industry. Our funders are allowed no influence on the content of the education on our platforms and our platforms are completely independent and provide an unbiased overview of the latest news and views in lymphoma. Access to funding from the pharmaceutical field is competitive and sometimes limited, so in order to continue to curate 24/7 updates and help HCPs to find everything they need to know about lymphoma in one space, we gratefully accept contributions from the public. We will use these contributions to create additional content for the Lymphoma Hub. Content that has been funded via contributions will be marked via a funding statement. As part of the contribution process you can choose to sign up to receive an annual report showcasing content that has been developed as a result of public contributions.

How do the hubs support HCPs?

Scientific data is growing by 20–40% every year; in 2023 alone there were 426,000 clinical studies registered, representing a 163% increase compared with 2022. The number of scientific publications indexed in PubMed has doubled since 2014, exceeding 30 million articles by the end of 2024. In lymphoma alone, in 2023 there were about 15,000 clinical papers published, which equates to nearly 40 papers a day, or 2 an hour!

Our hubs curate the latest news and views on lymphoma in one space and support HCPs to stay up-to-date on this rapidly changing field, so they can make informed decisions for their patients. The Lymphoma Hub is informed by patients, curated by world leaders, and endorsed by expert societies to provide HCPs with the latest clinically relevant, evidence-based scientific, medical, and clinical content, in micro-learning formats, to expedite learning, empower clinical decision-making, and optimize patient outcomes.

Who are Scientific Education Support?

Scientific Education Support (SES) is the independent medical education provider responsible for the creation of the Lymphoma Hub. Our team is made up of experienced medical writers and education designers, and we are guided by our expert steering committee and professional society partners . We are a for-profit and have created the hub through funding from the pharmaceutical industry. Our funders are allowed no influence on the content of the education on our platforms, and our platforms are completely independent and provide an unbiased overview of the latest news and views in lymphoma. Access to funding from the pharmaceutical field is competitive and sometimes limited, so in order to continue to curate 24/7 updates and help HCPs to find everything they need to know about lymphoma in one space, we gratefully accept donations from the public. We will use these donations to create additional content for the Lymphoma Hub. Content that has been funded via donations will be marked clearly with a funding statement.

How do you measure your impact, and how will you keep me updated?

We regularly survey our hubs’ users to check we are being successful in supporting them. In 2023, on average, 38.5% of HCPs who completed our pre-/post-activity tests improved their knowledge. The average satisfaction rating of our hubs was 4.65/5! If you would like to stay up-to-date with the Lymphoma Hub, please sign up to our newsletter. As part of the donation process, you can choose to sign up to receive an annual report showcasing content that has been developed as a result of public donations and the impact it has had.

What other services does Scientific Education Support provide?

SES currently runs the following hubs that mirror the offering of the Lymphoma Hub: ALL Hub, AML Hub, Multiple Myeloma Hub, MPN Hub, GvHD Hub, Lupus Hub, and Psoriasis Hub. To find out more about our educational offerings and stay up to date with SES, please sign up to our newsletter here.

I’m having trouble donating – can anyone help me?

Of course – please email us including the best contact number for you and the best times to reach you, and a member of the team will be in touch. Or, if you prefer to outline your problem over email, we can support you this way too: Secretariat@ScientificEducationSupport.com

How do you guarantee the content of the hubs is independent?

Each of our hubs is steered by an expert steering committee. All content is created by SES following guidance from the committee. Our hubs receive financial support by the pharmaceutical industry, but these supporters are allowed no influence on the content of the hubs. SES has been accepted as full members of the Good CME Practice group. To be eligible to join, candidate organizations must:

  • • Be a Europe-based academic or professional medical education provider; and
  • Agree to adhere to the principles of the Good CME Practice group.

In addition, full members must demonstrate a proven track record in the design, delivery, and evaluation of CME-accredited activities in Europe.

I would like to leave a gift in my will – how can I do this?

Who you choose to include in your will is a very personal and private matter; we are honoured that you are considering us. Please leave your gift to Scientific Education Support Ltd. If you would like further information before making this important decision, please don’t hesitate to contact us and we can arrange a call to discuss this with you further.

Is your online donation system secure?

All user credential and payment transactions are only submitted over secure connections, and we never store payment card details. We comply with the Payment Card Industry (PCI) security standards for all information, and we only use mainstream browsers for all transactions for security reasons.

How do you protect donors’ classified information?

We conform with GDPR guidance. Please review our Terms and Conditions and Privacy Policy for information on how we collect, store, and use data.

Is my donation tax deductible?

We are a for-profit organization, so your donation will not be classified as charitable giving.

Do you offer gift aid or gift matching?

No; as we are not a non-profit or charity, we are not eligible for gift aid or gift matching.

I am a potential supporter and would like to speak with your team

We would love to hear from you; please email us, and one of the team will be in touch to set up some time to speak further: Partnerships@ScientificEducationSupport.com

I have the contact details of a potential supporter – who should I speak to?

Thank you very much – we are always looking for introductions. Please email our partnerships team, and they will be happy to speak with you: Partnerships@ScientificEducationSupport.com

What is SES doing to demonstrate their commitment to DEI?

Recognizing that diversity is not the same as inclusion, our DEI committee is focused on providing a supportive organizational culture and encouraging an open dialogue among staff to converse and share problems and solutions. We are passionate about improving diversity and inclusion in our team and our platforms and establishing a sense of belonging for everyone. We understand there is more work to be done.

I have feedback to share – where can I share this?

We would love to hear from you, as your feedback will help us to continue to improve our service to HCPs. Please contact us here:Secretariat@ScientificEducationSupport.com

Have a question we didn't answer? Please contact us at Secretariat@ScientificEducationSupport.com.